🇺🇸 FDA
Pipeline program

REGN1908-1909

R1908-1909-ALG-1703

Phase 2 small_molecule completed

Quick answer

REGN1908-1909 for Cat Allergy is a Phase 2 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
REGENERON PHARMACEUTICALS, INC.
Indication
Cat Allergy
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials